European Journal of Clinical Pharmacology

, Volume 24, Issue 5, pp 623–628 | Cite as

Cleansing properties of stabilized trypsin and streptokinase-streptodornase in necrotic leg ulcers

  • L. Hellgren
Originals

Summary

The cleansing effects on pus and debris of streptokinase-streptodornase and of stabilized crystalline trypsin were compared in 40 patients (12 males, 28 females) with necrotic varicose or arteriosclerotic leg ulcers. Both preparations produced significant partial or total cleansing of the ulcers of necrotic material, and both enhanced the granulation and epithelialization of most of the ulcers. Streptokinase-streptodornase was significantly more effective in removing freshly formed damp and smearing pus and debris. Neither preparation prevented the formation of or removed very deep adherent necrotic areas, especially in arteriosclerotic leg ulcers. Trypsin caused significantly more pain than streptokinase-streptodornase during the treatment period and on changing dressings. Both enzymes indirectly reduced the bacterial flora of the ulcers, probably by removal of necrotic wet material.

Key words

necrotic leg ulcers crystalline trypsin streptokinase-streptodornase cleansing properties healing varicose ulcers arteriosclerotic ulcers 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Connell JF Jr, Rousselot LM (1951) The use of enzymatic agents in the debridement of burn and wound sloghs. Surgery 7: 43–55Google Scholar
  2. Hagelbäck B, Lundborg H (1982) Studies on the cytotoxic effect of enzyme preparations. Eur Surg Res (in press)Google Scholar
  3. Hedström S-Å (1980) Behandling av infekterade nekrotiska sår med Streptokinas-Streptodornaslösning. Opuse Med 25: 1–3Google Scholar
  4. Heilesen B (1954) Den terapeutiske virkning af trypsin ved nogle hudsygdomme. Ugeskr Laeg 116 [7] 248–250Google Scholar
  5. Hellgren L, Vincent J (1977) Degradation and liquefaction effect of streptokinase-streptodornase and stabilized trypsin on necroses, crusts of fibrinoid, purulent exudate and clotted blood from leg ulcers. J Int Med Res 5: 334–337Google Scholar
  6. Hillström L, Petterson L (1978) Den sårläkande effekten av Varidase® vid långtidsbehandling av venösa sår. Opusc Med 6: 151–155Google Scholar
  7. Howe C (1966) Experimental studies on determinants of wound infection. Surg Gynecol Obst 123 [1] 507Google Scholar
  8. Miles AA (1956) Nonspecific defense reactions in bacterial infections. Ann N Y Acad Sci 66: 366–368Google Scholar
  9. Nordquist P, Paulsen B, Ruth M (1981) En jämförande studie av smärtreaktionen vid användning av Trypure och Varidase. Läkartidningen 48: 43–49Google Scholar
  10. Northrop JH, Kunitz M (1948) Crystalline enzymes (2nd edn), New YorkGoogle Scholar
  11. Oey FTI, Bonnet J (1957) Experimental investigations into the pharmacotherapy of necroses of the skin. Arch Chir Neerl 9: 274–288Google Scholar
  12. Skog E (1977) Behandling av svårläkta bensår med Streptokinas-Streptodornaslösning. Opusc Med 5: 135–138Google Scholar
  13. Suomalainen O (1982) Evaluation of two enzyme preparations — Trypure and Varidase — in traumatic ulcers. (In preparation)Google Scholar
  14. Tiller WS, Garner PL (1933) Streptococcal enzymatic debridement. J Exp Med 58: 485Google Scholar
  15. Teitelman S, Lloyd M (1952) Enzymatic debridement of necrotic surfaces. Ann Surg 136: 267–271Google Scholar
  16. Wifling L (1960) Ein Beitrag zu den „gewebsverdauenden“ Medikamenten. Med Klin 12: 464–466Google Scholar

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • L. Hellgren
    • 1
  1. 1.Department of Dermatology, Faculty of MedicineUniversity of TrondheimTrondheimNorway

Personalised recommendations